Gabrielle Faure-André joined Regimbeau in 2008, after passing her Ph.D in the field of tumor immunology. Gabrielle then developed at Regimbeau a legal expertise for the patent protection of biotechnological inventions (genetic signatures, prognostic and diagnostic methods, biomarkers, antibodies, drugs, vaccines) as well as biochemical inventions (cosmetics, reagents, screening methods, enzymology).
Now a French and European patent Attorney, Gabrielle handles with complete autonomy the patent families of many start-ups and academic organizations, for which she builds IP strategies adapted to their needs and their budget. Always sensitive to environmental and biodiversity issues, Gabrielle is closely interested in the implementation of national laws governing access and use of genetic resources, these laws increasingly impacting the practice of patents.
Paris, 19 July 2023 – Regimbeau, a French and European intellectual property firm, announces the release of the second edition of its book providing economic stakeholders with an insight into…
ByBarbara Casadewall and Gabrielle Faure-André will discuss inventor compensation practices, the RGPD and the Research Tax Credit in this webinar dedicated to HealthTech HR issues.
ByParticipation of Barbara Casadewall and Gabrielle Faure-André at a meeting of the HR Commission, organized by France Biotech, about “Intellectual Property and inventors right”.
ByInterventions of Gabrielle Faure-André and Raphaëlle Gillet at the 4th edition of the Nagoya Protocol Conference.
ByRegimbeau organizes a breakfast conference on the theme: “Inventions of employees – Part 2: Remuneration of inventors, Issues and practices”. Interventions of Frédérique Faivre Petit, Philippe Bessiere, Anne Seibel and…
ByContribution by Cécile Puech on “Patent battles over antibody production (Upstream Processing) and territory constraints.” and participation of Gabrielle Faure-André at the 4th edition Bioproduction of Immunotherapies
ByRegimbeau is organising a 5-day training seminar on “European Patents and Designs: The Essentials” for clients and foreign colleagues wishing to acquire a working knowledge of the specificities of patent…
ByContribution by Gabrielle Faure-André at the Business-Research Day with a presentation on the theme “New regulations related to the Nagoya Protocol”.
ByRegimbeau is organizing a conference on “Biodiversity laws and issues on your IP strategy”. The debates will be led by the following French & European Patent Attorneys: Barbara Casadewall, Partner,…
ByContribution by Gabrielle Faure-André on “Traditional Knowledge, Traditional Cultural Expression, Genetic Resources, Nagoya Protocol, Towards New Forms of Intellectual Property?” at the ASPI conference
ByRegimbeau is organising a conference on: “Issues of Biodiversity Laws on Access, Exploitation and Intellectual Property Associated with Genetic Resources in Biotechnology”. Contribution by Claire NEIRAC and Alexandrine REY, PI…
ByParticipation of Gabrielle Faure-André in the “Nagoya Protocol Conference and ABS (access and benefit-sharing): what impact on your supply of plant resources for plant variety selection, acquisition or development?” organized…
ByParticipation of Gabrielle Faure-André, IP Attorney, at the Conference entitled “The Nagoya Protocol, Biodiversity here and abroad” organized by FEBEA, PRODAROM, ASPA INGRECOS and UNITIS. This conference took place at…
By
